- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 27.05. | 20/20 Biolabs Inc.: 20/20 Biolabs' Multi-Cancer Early Detection Blood Test Selected by State of Vermont to Screen up to 4,500 Firefighters | 2 | GlobeNewswire (USA) | ||
| 20/20 BIOLABS Aktie jetzt für 0€ handeln | |||||
| 22.05. | 20/20 Biolabs: Pläne für Ebola-Tests treiben Aktie an | 1 | Investing.com Deutsch | ||
| 22.05. | 20/20 Biolabs Inc.: 20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing if Outbreak Creates Overflow Demand | 2 | GlobeNewswire (USA) | ||
| 20.05. | 20/20 Biolabs, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 20.05. | 20/20 Biolabs, Inc. GAAP EPS of -$0.28 misses by $0.18, revenue of $0.35M misses by $0.43M | 1 | Seeking Alpha | ||
| 20.05. | 20/20 Biolabs, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 12.05. | 20/20 Biolabs Inc.: 20/20 BioLabs Exclusively Licenses PSA Velocity Algorithm from the University of South Carolina | 1 | GlobeNewswire (USA) | ||
| 28.04. | 20/20 Biolabs, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 10.04. | RedChip Companies, Inc.: BIO-key International, 20/20 Biolabs, Society Pass, and Soligenix Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 633 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / April 10, 2026 / RedChip Companies will air interviews with BIO-key International, Inc. (Nasdaq:BKYI), 20/20 Biolabs, Inc. (Nasdaq:AIDX), Society Pass Inc. (Nasdaq:SOPA)... ► Artikel lesen | |
| 07.04. | 20/20 Biolabs Inc.: 20/20 BioLabs Selected by Evexia Diagnostics to Offer OneTest for Cancer Through Evexia Platform | 2 | GlobeNewswire (USA) | ||
| 06.04. | 20/20 Biolabs, Inc. - S-1, General form for registration of securities | - | SEC Filings | ||
| 01.04. | 20/20 Biolabs, Inc. GAAP EPS of -$0.76, revenue of $2M | 1 | Seeking Alpha | ||
| 01.04. | 20/20 Biolabs, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 31.03. | 20/20 Biolabs Inc.: 20/20 BioLabs Reports Full Year 2025 Financial Results and Recent Operational Progress | 205 | GlobeNewswire (Europe) | Full Year 2025 Revenue of $2.0 Million, up 17% from 2024 Gross Profit Increased 68% in FY 2025 and Gross Margin Expanded 900 bps State-Funded Firefighter Cancer Screening Program Expected to Drive... ► Artikel lesen | |
| 31.03. | 20/20 Biolabs, Inc. - 10-K, Annual Report | - | SEC Filings | ||
| 27.03. | 20/20 Biolabs Unchanged on News | 1 | Baystreet.ca | ||
| 27.03. | 20/20 Biolabs Inc.: Maryland Fire Departments Awarded $520,000 for Cancer Screenings using 20/20 BioLabs' OneTest Multi-Cancer Early Detection Blood Test | 5 | GlobeNewswire (USA) | ||
| 24.03. | 20/20 Biolabs Inc.: 20/20 BioLabs Announces Exclusive U.S. License Agreement with ROKIT Healthcare to Integrate Advanced CKD Prediction Technology into Its Longevity Test Program | 413 | GlobeNewswire (Europe) | Inflammatory Biomarker Tracking Predicted to Enhance Response to 3-D Bio-Printed Therapies Expands OneTest for Longevity with Chronic Kidney Disease Risk Assessment GAITHERSBURG, Md., March 24,... ► Artikel lesen | |
| 12.03. | 20/20 Biolabs Inc.: 20/20 BioLabs Highlights Advantages of its Patented Protein Biomarker Technology for Multi-Cancer Early Detection in Light of Recent Studies | 1 | GlobeNewswire (USA) | ||
| 25.02. | 20/20 Biolabs Inc.: 20/20 BioLabs Launches OneTest for Longevity Blood Test and Chronic Disease Risk Assessment and Management Solution Built with IBM AI Capabilities | 505 | GlobeNewswire (Europe) | Recently Nasdaq-Listed Company Introduces Longevity Blood Test Integrating Inflammatory Biomarkers, Dietary Habits, and Curated Scientific Research to Deliver Personalized Health Insights GAITHERSBURG... ► Artikel lesen |
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 37,170 | +0,68 % | UBS stuft Fresenius SE auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat Fresenius mit einem Kursziel von 54 Euro auf "Buy" belassen. Die jüngsten Empfehlungen des Bundesrats zur geplanten Reform des deutschen Gesundheitssystems... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,190 | -0,05 % | Alignment Healthcare, Inc. - 8-K, Current Report | ||
| SIEMENS HEALTHINEERS | 35,090 | +2,09 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,630 | +1,76 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 61,01 | +0,02 % | Goldman Sachs initiates BrightSpring Health stock at Buy with $71 target | ||
| GENEDX | 56,46 | +0,23 % | Sema4.ai's autonomous agent building platform gets simpler to use, adds deeper business context and more | ||
| LIFESTANCE HEALTH GROUP | 7,660 | 0,00 % | Goldman Sachs initiates Lifestance Health stock at neutral | ||
| PROGYNY | 25,810 | -0,08 % | Progyny, Inc.: New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System | ||
| CARL ZEISS MEDITEC | 25,780 | -1,75 % | Aktien - Shortseller-Positionen: Carl Zeiss Meditec, Evotec, HelloFresh, Kontron, LPKF Laser, TeamViewer | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| BILLIONTOONE | 102,44 | +0,05 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 22,150 | -0,09 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2026 Financial Results | Strong First Quarter Performance and Operating ExecutionReiterated Full-Year 2026 Guidance Reflects Continued Momentum ARLINGTON, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq:... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 28,780 | 0,00 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| QTREX QUANTUM | 1,580 | -1,25 % | QTREX Spikes on $1M Grant | ||
| UNITEDHEALTH | 357,20 | -0,17 % | Aktien New York Ausblick: Techwerte unter Druck nach KI-Ausblick von Broadcom | NEW YORK (dpa-AFX) - Ein enttäuschender Ausblick des Chipkonzerns Broadcom dürfte am Donnerstag für Moll-Stimmung an der Technologiebörse Nasdaq sorgen. Der Broker IG taxierte den viel beachteten Branchenindex... ► Artikel lesen | |
| AIRSCULPT TECHNOLOGIES | 5,280 | 0,00 % | Airsculpt Technologies, Inc.: AirSculpt Technologies Reports First Quarter Fiscal 2026 Results | MIAMI BEACH, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced... ► Artikel lesen |
Das Unternehmen 20/20 BIOLABS INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,792 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu 20/20 BIOLABS INC finden Sie auf Wallstreet Online.